These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3463370)

  • 1. Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases.
    Encabo G; Ruibal A
    Bull Cancer; 1986; 73(3):256-9. PubMed ID: 3463370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum CA 50 in benign non-hepatic diseases].
    Genollá J; Mañé S; Gris JM; Ruibal A
    Med Clin (Barc); 1987 Feb; 88(5):214. PubMed ID: 3470582
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of serum CA 72.4 in patients with non-tumor pathologies. Preliminary results].
    Sagredo E; Soriano A; Pombo L; Ruibal A
    Med Clin (Barc); 1989 Jan; 92(2):78-9. PubMed ID: 2709892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
    Yoshimura R; Satake K
    Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basic studies and the reference values of cancer associated antigen CA-50].
    Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M
    Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M
    Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A
    Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer).
    Ruibal A; Encabo G; Genollá J; Guarga A; Urrutia A; Colomer R
    Bull Cancer; 1986; 73(1):94-5. PubMed ID: 3465383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Change of the content of electrolytes in plasma, erythrocytes and urine in patients with diseases of liver and biliary tract].
    Tagibekov KG; Zimovskiĭ VL
    Vrach Delo; 1969 May; 5():43-5. PubMed ID: 5368885
    [No Abstract]   [Full Text] [Related]  

  • 12. [The behavior of blood CA 15.3 in patients with non-tumor pathologies. Preliminary results].
    Ruibal A; Guarga A; Encabo G; Gris JM
    Med Clin (Barc); 1986 Feb; 86(6):262. PubMed ID: 3458017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease].
    Ruibal A; Siurana R; Encabo G; Cuartero A
    Med Clin (Barc); 1985 Mar; 84(9):376-7. PubMed ID: 3857424
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical study.
    Collazos J; Genolla J; Ruibal A
    Am J Gastroenterol; 1993 Mar; 88(3):409-12. PubMed ID: 8438849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R
    Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum CA 15.3 in women with non-tumor breast pathologies. Initial results].
    Ruibal A; Colomer R; Gris JM; Genollá J
    Med Clin (Barc); 1986 Sep; 87(9):393-4. PubMed ID: 3467152
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum interleukin 6 in the prognosis of acute biliary pancreatitis.
    Pezzilli R; Miniero R; Cappelletti O; Barakat B
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):291-4. PubMed ID: 9759598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies].
    Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J
    Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of carbohydrate antigen 19-9 in the adult and the child. Preliminary results].
    Capocasale E; Banchini B; Nori G; de Angelis GL; Gregori G
    Minerva Dietol Gastroenterol; 1986; 32(2):135-8. PubMed ID: 3461312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.